Acute Ischemic Stroke Ais Clinical Trials
2 recruiting trials for Acute Ischemic Stroke Ais. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Acute Ischemic Stroke Ais clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Euphrates Vascular, Inc. (1), University of South Florida (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Pulse NanoMED System (device, 1 trial), followed by Use of a Balloon Guide Catheter, Use of a Conventional (non-balloon) Guide Catheter.
Track Acute Ischemic Stroke Ais trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Pulse Endovascular ReperFUSION for Acute Ischemic Stroke
Prospective, multi-center, single-arm early feasibility study enrolling a minimum of 15 subjects at up to a minimum of 3 active investigational sites in the United States. The...
Balloon Guide Versus Conventional Guide Catheter in Stroke Thrombectomy
The purpose of this clinical trial is to study the two main types of approaches used in stroke thrombectomy and to investigate if one approach is more effective than the other, as...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Acute Ischemic Stroke Ais, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Acute Ischemic Stroke Ais, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Acute Ischemic Stroke Ais, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.